Münstedt K, Manthey N, Sachsse S, Vahrson H. Changes in self-concept and body image during alopecia induced cancer chemotherapy. Support Care Cancer. 1997;5(2):139–43.

Article  PubMed  Google Scholar 

McGarvey EL, Baum LD, Pinkerton RC, Rogers LM. Psychological sequelae and alopecia among women with cancer. Cancer Pract. 2001;9(6):283–9.

Article  CAS  PubMed  Google Scholar 

Trüeb RM. Chemotherapy-induced alopecia. Curr Opin Support Palliat Care. 2010;4(4):281–4.

Article  PubMed  Google Scholar 

Freites-Martinez A, Shapiro J, Goldfarb S, Nangia J, Jimenez JJ, Paus R, et al. Hair disorders in patients with cancer. J Am Acad Dermatol. 2019;80(5):1179–96.

Article  PubMed  Google Scholar 

Phillips GS, Freret ME, Friedman DN, Trelles S, Kukoyi O, Freites-Martinez A, et al. Assessment and treatment outcomes of persistent radiation-induced alopecia in patients with cancer. JAMA Dermatol. 2020;156(9):963–72.

Article  PubMed  Google Scholar 

Hedén L, Pöder U, von Essen L, Ljungman G. Parents’ perceptions of their child’s symptom burden during and after cancer treatment. J Pain Symptom Manage. 2013;46(3):366–75.

Article  PubMed  Google Scholar 

Barth JH. Normal hair growth in children. Pediatr Dermatol. 1987;4(3):173–84.

Article  CAS  PubMed  Google Scholar 

Wade MS, Sinclair RD. Disorders of hair in infants and children other than alopecia. Clin Dermatol. 2002;20(1):16–28.

Article  PubMed  Google Scholar 

Paus R, Haslam IS, Sharov AA, Botchkarev VA. Pathobiology of chemotherapy-induced hair loss. Lancet Oncol. 2013;14(2):e50–9.

Article  CAS  PubMed  Google Scholar 

Chon SY, Champion RW, Geddes ER, Rashid RM. Chemotherapy-induced alopecia. J Am Acad Dermatol. 2012;67(1):e37-47.

Article  PubMed  Google Scholar 

Haslam IS, Smart E. Chemotherapy-induced hair loss: the use of biomarkers for predicting alopecic severity and treatment efficacy. Biomark Insights. 2019;14:1177271919842180.

Article  PubMed  PubMed Central  Google Scholar 

Miteva M, Misciali C, Fanti PA, Vincenzi C, Romanelli P, Tosti A. Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases. Am J Dermatopathol. 2011;33(4):345–50.

Article  PubMed  Google Scholar 

Basilio FM, Brenner FM, Werner B, Rastelli GJ. Clinical and histological study of permanent alopecia after bone marrow transplantation. An Bras Dermatol. 2015;90(6):814–21.

Article  PubMed  PubMed Central  Google Scholar 

Bernárdez C, Molina-Ruiz AM, Requena L. Histologic features of alopecias-part I: nonscarring alopecias. Actas Dermosifiliogr. 2015;106(3):158–67.

Article  PubMed  Google Scholar 

Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12–49.

Article  PubMed  Google Scholar 

Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103.

Article  PubMed  Google Scholar 

Denburg AE, Fundytus A, Khan MS, Howard SC, Antillon-Klussmann F, Sengar M, et al. Defining essential childhood cancer medicines to inform prioritization and access: results from an international, cross-sectional survey. J Glob Oncol. 2022;8:e2200034.

Article  Google Scholar 

Bresters D, Wanders DCM, Louwerens M, Ball LM, Fiocco M, van Doorn R. Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood. Bone Marrow Transplant. 2017;52(7):984–8.

Article  CAS  PubMed  Google Scholar 

Choi EK, Kim IR, Chang O, Kang D, Nam SJ, Lee JE, et al. Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients. Psychooncology. 2014;23(10):1103–10.

Article  PubMed  Google Scholar 

Vowels M, Chan LL, Giri N, Russell S, Lam-Po-Tang R. Factors affecting hair regrowth after bone marrow transplantation. Bone Marrow Transplant. 1993;12(4):347–50.

CAS  PubMed  Google Scholar 

Sous D, Armstrong AE, Huang JT, Shah S, Carlberg VM, Coughlin CC. Cutaneous reactions to pediatric cancer treatment: part I. Conventional chemotherapy. Pediatr Dermatol. 2021;38(1):8–17.

Article  PubMed  Google Scholar 

Sweeney MJ, Tuttle AH, Etteldorf JN, Whittington GL. Cyclophosphamide in the treatment of common neoplastic diseases of childhood. J Pediatr. 1962;61:702–8.

Article  CAS  PubMed  Google Scholar 

Heyn RM, Beatty EC Jr, Hammond D, Louis J, Pierce M, Murphy ML, et al. Vincristine in the treatment of acute leukemia in children. Pediatrics. 1966;38(1):82–91.

Article  CAS  PubMed  Google Scholar 

Belum VR, Washington C, Pratilas CA, Sibaud V, Boralevi F, Lacouture ME. Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: a pooled analysis. Pediatr Blood Cancer. 2015;62(5):798–806.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carlberg VM, Davies OMT, Brandling-Bennett HA, Leary SES, Huang JT, Coughlin CC, et al. Cutaneous reactions to pediatric cancer treatment part II: targeted therapy. Pediatr Dermatol. 2021;38(1):18–30.

Article  PubMed  Google Scholar 

Song H, Zhong CS, Kieran MW, Chi SN, Wright KD, Huang JT. Cutaneous reactions to targeted therapies in children with CNS tumors: a cross-sectional study. Pediatr Blood Cancer. 2019;66(6): e27682.

Article  CAS  PubMed  Google Scholar 

Boull CL, Gardeen S, Abdali T, Li E, Potts J, Rubin N, et al. Cutaneous reactions in children treated with MEK inhibitors, BRAF inhibitors, or combination therapy: a multicenter study. J Am Acad Dermatol. 2021;84(6):1554–61.

Article  CAS  PubMed  Google Scholar 

Aplenc R, Blaney SM, Strauss LC, Balis FM, Shusterman S, Ingle AM, et al. Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children’s oncology group phase I consortium. J Clin Oncol. 2011;29(7):839–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Widemann BC, Kim A, Fox E, Baruchel S, Adamson PC, Ingle AM, et al. A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children’s Oncology Group Phase I Consortium report. Clin Cancer Res. 2012;18(21):6011–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Geoerger B, Morland B, Ndiaye A, Doz F, Kalifa G, Geoffray A, et al. Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium. Eur J Cancer. 2009;45(13):2342–51.

Article  CAS  PubMed  Google Scholar 

Jaing TH, Wang YL, Chiu CC. Immune checkpoint inhibitors for pediatric cancers: is it still a stalemate? Pharmaceuticals (Basel). 2024;17(8):991.

Article  CAS  PubMed  Google Scholar 

Zarbo A, Belum VR, Sibaud V, Oudard S, Postow MA, Hsieh JJ, et al. Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors. Br J Dermatol. 2017;176(6):1649–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Geisler AN, Phillips GS, Barrios DM, Wu J, Leung DYM, Moy AP, et al. Immune checkpoint inhibitor-related dermatologic adverse events. J Am Acad Dermatol. 2020;83(5):1255–68.

Article  CAS